Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dow P Hurst

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Medicinal Chemistry|July 26, 2015
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonistsGiulio Ragusa, María Gómez-Cañas, Paula Morales, et al.
Journal of Medicinal Chemistry|June 17, 2016
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple SclerosisPaula Morales, María Gómez-Cañas, Gemma Navarro, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity RelationshipLaura Figuerola-Asencio, Paula Morales, Pingwei Zhao, et al.
European Journal of Medicinal Chemistry|January 28, 2023
Design, synthesis, and evaluation of substituted alkylindoles that activate G protein-coupled receptors distinct from the cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptorsToni Kline, Cong Xu, Faith R Kreitzer, et al.
ACS Chemical Neuroscience|April 6, 2016
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding ProbeRobert B Laprairie, Abhijit R Kulkarni, Pushkar M Kulkarni, et al.
Journal of Medicinal Chemistry|July 8, 2005
Adamantyl cannabinoids: a novel class of cannabinergic ligandsDai Lu, Zhaoxing Meng, Ganesh A Thakur, et al.
Bioorganic & Medicinal Chemistry|July 5, 2017
Design, synthesis and biological evaluation of GPR55 agonistsLara Fakhouri, Christopher D Cook, Mohammed H Al-Huniti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 16, 2015
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent BehaviorMiriam Schneider, Fernando Kasanetz, Diane L Lynch, et al.
Journal of Medicinal Chemistry|October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamidesValentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
Biochemistry|May 4, 2011
Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Karla E Madrigal, Dow P Hurst, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Medicinal Chemistry|July 26, 2015
Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB2 receptor antagonistsGiulio Ragusa, María Gómez-Cañas, Paula Morales, et al.
Journal of Medicinal Chemistry|June 17, 2016
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple SclerosisPaula Morales, María Gómez-Cañas, Gemma Navarro, et al.
ACS Medicinal Chemistry Letters|January 19, 2023
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity RelationshipLaura Figuerola-Asencio, Paula Morales, Pingwei Zhao, et al.
European Journal of Medicinal Chemistry|January 28, 2023
Design, synthesis, and evaluation of substituted alkylindoles that activate G protein-coupled receptors distinct from the cannabinoid CB<sub>1</sub> and CB<sub>2</sub> receptorsToni Kline, Cong Xu, Faith R Kreitzer, et al.
ACS Chemical Neuroscience|April 6, 2016
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding ProbeRobert B Laprairie, Abhijit R Kulkarni, Pushkar M Kulkarni, et al.
Journal of Medicinal Chemistry|July 8, 2005
Adamantyl cannabinoids: a novel class of cannabinergic ligandsDai Lu, Zhaoxing Meng, Ganesh A Thakur, et al.
Bioorganic & Medicinal Chemistry|July 5, 2017
Design, synthesis and biological evaluation of GPR55 agonistsLara Fakhouri, Christopher D Cook, Mohammed H Al-Huniti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 16, 2015
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent BehaviorMiriam Schneider, Fernando Kasanetz, Diane L Lynch, et al.
Journal of Medicinal Chemistry|October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamidesValentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
Biochemistry|May 4, 2011
Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligandsEvangelia Kotsikorou, Karla E Madrigal, Dow P Hurst, et al.
Pageof 6